Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1533421 NEW YORK, NY
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$36,169
+$35,426 QoQ
Shares Held
7,745
+4202.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 89 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,738,477 across 465 Biotechnology names. XFOR ranks #167 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in XFOR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,169 7,745
2026-03-31 $743 180
2025-12-31 $41,784 10,446
2025-09-30 $36,522 10,679
2025-06-30 $9,885 5,203
2025-03-31 $7,209 30,550
2024-12-31 $11,440 15,587
2024-09-30 $7,209 10,776
2024-06-30 $15,638 26,963
2024-03-31 $22,529 16,209
2023-12-31 $10,351 12,338
2023-09-30 $11,201 10,277
2023-06-30 $11,292 5,821
2023-03-31 $1 810
2022-12-31 $10,155 10,227
2022-06-30 $5,441 5,639
2022-03-31 $16,965 9,695
2021-09-30 $6,612 1,250
2021-06-30 $86,000 13,231
2021-03-31 $26,028 3,023
2020-12-31 $39,377 6,124
2020-09-30 $119,070 17,588
2020-06-30 $28,724 3,082